|
WO2020165402A1
|
|
Gd2-upregulation by ezh2 inhibition in cancer therapy
|
|
WO2017093351A1
|
|
Cpla2 inhibitors
|
|
DE102016104210A1
|
|
Use of trialkylsiloxy-based metal complexes as an additive in lithium-ion batteries
|
|
EP3248015A1
|
|
Compounds and methods for the detection of calprotectin
|
|
EP3184536A1
|
|
Oligosaccharide composition for binding to lectins
|
|
DE102015016138A1
|
|
Ultrasound probe guide belt, system and method of use
|
|
WO2017092792A1
|
|
Surface modified lithium-rich oxides
|
|
EP3168211A1
|
|
Pharmaceutical co-crystals of niclosamide
|
|
DE102015112343A1
|
|
Apparatus and method for processing body fluids
|
|
WO2016134765A1
|
|
Electrode material for lithium-ion batteries and preparation method thereof
|
|
EP2848691A1
|
|
Broad host range expression vector for diverse prokaryotes
|
|
EP2800197A1
|
|
Fluorinated carbonates as solvent for lithium sulfonimide-based electrolytes
|
|
EP2581785A1
|
|
Two-dimensional electrochemical writing assembly and use thereof
|
|
DE102009046504A1
|
|
Method and device for analyzing a substance mixture
|
|
EP2092062A2
|
|
Zeolite crystals with biological material
|
